FKFiliz Kizilateş

Filiz Kizilateş

*This is an algorithmically generated author record based on publicly available information.

Filiz Kizilateş has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Value of Lymphocyte-CRP Ratio Predicting the Prognosis in COVID-19 Patients

    by Alper Tahmaz, Ayşegül Şeremet Keskin, Filiz Kizilateş, Nefise Öztorpak

    Introduction: Although prevention of the disease and its spread is the primary goal in the fight against the pandemic, studies on the correct management of those who have the disease and the predictability of the prognosis are also important. This study aimed to determine whether lymphocyte-C-reactive protein ratio, together with other inflammation markers, would be useful in predicting intensive care unit admission and mortality in Coronavirus disease 2019 cases. Material and methods: 883 patients were followed in 758 wards and 125 intensive care units. Data of the patients included in the study were compared with those admitted to the service and intensive care unit, and with those who survived and developed mortality. Results: According to the receiver operating characteristic analysis to distinguish the patients followed in the intensive care unit from the patients hospitalized in the ward that was determined that lymphocyte-C-reactive protein ratio, C-reactive protein ratio, CRP-albumin ratio, and neutrophil-lymphocyte ratio were moderate (70%–80%). D-dimer was good (80%–90%) predicting follow-up in intensive care unit. Increase in age, increase in lactate dehydrogenase and interleukin-6 levels, and uptake in tomography were determined as independent risk factors that increase intensive care unit admission. 243 (27.5%) of the patients were mortal. The mean age of the patients with a mortal course was 70±14 years, and mortality increased with increasing age. In the receiver operating characteristic analysis of patients with a mortal course that was determined that lymphocyte-C-reactive protein ratio, neutrophil-lymphocyte ratio, and D-dimer had a good (80–90%) ability to distinguish patients with a mortal course. Age, fever, and increases in lactate dehydrogenase and interleukin-6 levels were determined to be independent risk factors increasing mortality. Conclusions: Low lymphocyte-C-reactive protein ratio and high D-Dimer, neutrophil-lymphocyte ratio, and CRP-albumin ratio can be used in clinical monitoring to reduce morbidity and mortality rates due to COVID-19.

  • The effect of intubation type and place of intubation on the development of ventilator-associated pneumonia

    by Kübra Demi̇r Önder, Ayşegül SEREMET KESKİN, Filiz Kizilateş, Mustafa Deni̇z

    Amaç: Çalışmamızda entübasyon türünün (elektif veya acil) ve entübasyonun yapıldığı ortamın, ventilatör ilişkili pnömoni (VİP) gelişimi üzerine etkisinin incelenmesi amaçlanmıştır. Yöntem: 1 Şubat 2019 ve 28 Şubat 2020 tarihleri arasında VİP tanısı almış, erişkin hastalar çalışmaya alındı. Yatış nedeni, entübasyon türü (elektif, acil), entübasyonun yapıldığı yer (ambulans, acil servis, yatan hasta servisi, yoğun bakım, ameliyathane), VİP gelişene kadar geçen süre ve mortalite durumları retrospektif olarak incelendi. Bulgular: Çalışmaya 180 VİP tanılı hasta dahil edildi. Hastaların %55’ ine acil entübasyon, %45’ ine elektif entübasyon yapıldığı saptandı. Entübasyon sonrası VİP gelişimine kadar geçen ortalama süre 7,9 ± 5,9 gündü. Acil entübasyonlarda VİP gelişimine kadar geçen süre elektif entübasyonlara göre daha kısa idi (sırasıyla 6.8± 4.58 vs 9.1± 7.09 gün, p=0.023). Hastaların %33.9’unun yoğun bakımda, %26.7’ sının acil serviste, %17.2’sinin ameliyat öncesinde, %11.7’sinin yatan hasta servisinde ve %10.6’sının hastaneye getirilmeden önce entübe edildiği görüldü. 7 gün mortalite %20, 14 gün mortalite %36.7, 30 gün mortalite %46.7 olarak saptandı. Kaba mortalite ve entübasyonun yapıldığı yer arasında istatiksel anlamlı ilişki saptanmadı (p=0.366). Acil entübasyon yapılan hastalarda VİP sonrası 7, 14 ve 30 gün mortalite oranlarının elektif entübasyona göre daha fazla olduğu saptandı. Sonuç: Acil entübasyonlarda elektiflere göre VİP gelişme süresinin daha kısa olduğu (p=0,009) ve tüm nedenlere bağlı mortalitenin istatistiksel anlamlı fark olmasa da acil entübasyon yapılanlarda elektif entübasyon yapılanlara göre daha fazla olduğu saptandı. Enfeksiyon kontrol önlemlerinin acil entübasyonlarda tam uygulanamamasının bu sonuca neden olduğu düşünüldü.

  • Evaluation of extensively drug-resistant gram-negative bacteremia among solid-organ transplant recipients: a multicenter study

    by Tuğba YANIK YALÇIN, Özlem Azap, Adem Köse, Yaşar BAYINDIR, Elif Mükime Saricaoğlu, Güle Çinar, Yeşim UYGUN KIZMAZ, Ebru Kurşun, Hikmet Eda Alişkan, Yasemin Tezer Tekçe, et al.

    Background/aim: The aim of this study is to evaluate the distribution, sources, clinical features, and mortality rates of bacteremia due to evaluation of extensively drug-resistant (XDR) gram negative among solid-organ transplant (SOT) recipients. Materials and methods: A retrospective study of SOT recipients with bacteremia due to XDR gram-negative pathogens in 11 centers between 2016 and 2018 was conducted. Patients' records were evaluated. Results: Of 171 bacteremia that occurred in 164 SOT recipients, 93 (56.7%) were liver, 46 (28%) kidney, 14 (8.5%) heart, and 11 (6.7%) lung recipients. Bacteremia episodes were recorded in the first year in 63.7% of the patients (n = 109), early-onset bacteremia was recorded in 45% (n = 77) of the episodes. In multivariate analysis, catheter-associated bacteremia was an independent risk factor for 7-day mortality (p = 0.037), and early-onset bacteremia was found as an independent risk factor for 30-day mortality (p = 0.017). Conclusion: Difficult-to-treat infections due to XDR bacteria in SOT recipients shadow the success of transplantation. Central venous catheters seem to be the main risk factor. Judicious use of medical devices is of pivotal importance.